Jump to content
IndiaDivine.org

communicatio from Congressman Wu's Office OR

Rate this topic


Guest guest

Recommended Posts

Jeanne:

 

 

 

This bill is in no way intended to curtail dietary supplements and it

will not restrict over the counter purchase. The bill as passed

requires a manufacturer, packer, or distributor of dietary supplements

to: (1) submit to the Secretary of HHS within 15 business days any

report of a serious adverse event associated with use of such drug or

supplement in the United States; (2) submit within 15 business days

any related medical information that is received within one year of

the initial report; (3) maintain records related to each report for

six years; and (4) permit inspection of such records. It also requires

the Secretary to develop systems to ensure that duplicate reports of a

serious adverse event are consolidated. It is just a way to keep track

of dangerous outcomes, which has definitely happened with certain

supplements, like ephedra.

 

 

 

As to HR 2995/S517, the Congressman has not taken a formal position on

the bill yet, but I can tell you he has voiced concerns that this

subject area but not be entered into lightly.

 

 

 

Hope this helps.

Link to comment
Share on other sites

Pretty much all "bills" developed by these guys represent either overtly or covertly agendas that always direct themselves to increasing the wealth and power of the medical, pharmaceutical (chemical) industries, and eliminating competition for them. I don't have any idea why alternative/complementary health welcomes them at all. Just leave us the hell alone.

 

-

mirakulu2003

Wednesday, December 13, 2006 1:17 AM

communicatio from Congressman Wu's Office OR

 

 

Jeanne:This bill is in no way intended to curtail dietary supplements and itwill not restrict over the counter purchase. The bill as passedrequires a manufacturer, packer, or distributor of dietary supplementsto: (1) submit to the Secretary of HHS within 15 business days anyreport of a serious adverse event associated with use of such drug orsupplement in the United States; (2) submit within 15 business daysany related medical information that is received within one year ofthe initial report; (3) maintain records related to each report forsix years; and (4) permit inspection of such records. It also requiresthe Secretary to develop systems to ensure that duplicate reports of aserious adverse event are consolidated. It is just a way to keep trackof dangerous outcomes, which has definitely happened with certainsupplements, like ephedra.As to HR 2995/S517, the Congressman has not taken a formal position onthe bill yet, but I can tell you he has voiced concerns that thissubject area but not be entered into lightly.Hope this helps.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...